CMPX peer analysis
Compass Therapeutics (CMPX) against its competitors: price, today's move, 1-year return and market value side by side.
- CMPX's peers: BCYC (Bicycle Therapeutics), CRVS (Corvus Pharmaceuticals), FDMT (4D Molecular), FULC (Fulcrum Therapeutics), GOSS (Gossamer Bio), LXRX (Lexicon Pharmaceuticals), MNPR (Monopar Therapeutics), OCGN (Ocugen).
CMPX and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| BCYC Bicycle Therapeutics | $2.90 | -4.92% | -53.60% | $203.27M |
| CRVS Corvus Pharmaceuticals | $9.67 | -3.40% | 8.65% | $815.69M |
| FDMT 4D Molecular | $10.23 | -4.57% | -5.28% | $740.49M |
| FULC Fulcrum Therapeutics | $3.68 | -0.81% | -68.03% | $281.09M |
| GOSS Gossamer Bio | $10.80 | -3.78% | -95.70% | $66.09M |
| LXRX Lexicon Pharmaceuticals | $1.50 | -10.03% | 3.62% | $668.96M |
| MNPR Monopar Therapeutics | $67.35 | -4.19% | -18.86% | $456.39M |
| OCGN Ocugen | $0.77 | 5.70% | -32.05% | $262.83M |
| OMER Omeros | $13.19 | -5.85% | 60.46% | $982.17M |
| CMPX Compass Therapeutics | $0.67 | -0.87% | -86.27% | $121.13M |